Altimmune, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -45.6% | -45.6% | -42.0% |
| FY2024 | -77.0% | -77.0% | -68.2% |
| FY2025 | -39.2% | -34.0% | -31.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -45.6% | -45.6% | -42.0% |
| FY2024 | -77.0% | -77.0% | -68.2% |
| FY2025 | -39.2% | -34.0% | -31.5% |